ACTRN12619000920190
Terminated
未知
on-healing soft tissue and malignant wounds in the palliative care setting: feasibility of applying Sterile Larvae Wound Therapy for wound debridement and healing.
St Vincent's Private Hospital Brisbane0 sites1 target enrollmentJuly 2, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- malignant wounds
- Sponsor
- St Vincent's Private Hospital Brisbane
- Enrollment
- 1
- Status
- Terminated
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)with advanced disease who are inpatients of the SVPHB palliative care unit
- •2\)have a non\-healing soft tissue or malignant wound with one or more of the following elements
- •onecrotic tissue
- •omalodorous
- •oprofuse exudate
Exclusion Criteria
- •1\)have an allergy to fly larvae, chicken eggs or soybeans.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical and Radiologic Evaluation of Wound Healing After Extraction of Impacted Third Molars in Hypothyroid PatientsTCTR20240802005Akdeniz University, Dentistry Faculty40
Not yet recruiting
Not Applicable
Comparison of soft tissue healing after tooth socket preservation technique using gelatin sponge with or without i-PRF, in systemically healthy adult individuals: A Split-Mouth double blindedrandomized controlled clinical trial.Health Condition 1: K088- Other specified disorders of teethand supporting structuresCTRI/2023/01/048767DR SAYALI KUTE
Recruiting
Phase 3
Regenerative Therapy for Soft Tissue Defects of the External Auditory Meatus with NPC-18Subject has soft tissue defect of external auditory meatus resulting from injury or postoperative daRegenerative Therapy,External auditory meatus defects, Gelatin sponge, Basic fi broblast growth factor ,Fibrin glueJPRN-jRCT2051230028Kanemaru Shin-ichi20
Not yet recruiting
Phase 2
Management of wound by an ayurvedic ointment.Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereCTRI/2024/07/070969Shri BMK AMV
Completed
Phase 4
Treatment of wound healing disorders in patients with diabetic foot syndrome caused by diabetic neuropathy (neuropathic foot), or diabetic angiopathy (gangrene) with the medical device TOXAPREVENT SKIN® skin powder and early detection of a possible wound infection by MEANS of VOC analysis by MCC-IMSE14.7T79.3Post-traumatic wound infection, not elsewhere classifiedDRKS00025056FROXIMUN AG50